0.000USD0.000Pre-market 11/06, 09:30 (ET)
50.70MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Spectral AI Inc
Currency: USD Updated: 2025-11-05 Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy.
Spectral AI Inc's Score
Score Analysis
Current score
Previous score
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Spectral AI Inc Highlights
StrengthsRisks
Financial Health
Currency: USD Updated: 2025-11-05The company's current financial score is 6.58, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 5.07M, representing a year-over-year decrease of 32.27%, while its net profit experienced a year-over-year decrease of 178.21%.
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Key Metrics
Total revenue
Operating profit
Total assets
SG&A
No Data
Key Metrics
Cash flow from operating activities
Income after tax
No Data
Key Metrics
Cash flow from operating activities
Total revenue
No Data
Key Metrics
No Data
Spectral AI Inc's Company Valuation
Currency: USD Updated: 2025-11-05The company’s current valuation score is 6.73, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -2.79, which is -100.00% below the recent high of 0.00 and -1949.51% above the recent low of -57.16.
Valuation Dimensions
Industry Ranking 146/210
No Data
Earnings Forecast
Currency: USD Updated: 2025-11-05The company’s current earnings forecast score is 8.67, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Spectral AI Inc is 4.25, with a high of 7.45 and a low of 3.50.
Support & Resistance
No Data
Strong Buy
Buy
Hold
Sell
Strong Sell
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
35
Thermo Fisher Scientific Inc
TMO
28
Financial Forecasting
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-11-05There is no price momentum score for this company; the Healthcare Equipment & Supplies industry's average is 6.82.
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Institutional Confidence
Currency: USD Updated: 2025-11-05The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 12.59%, representing a quarter-over-quarter decrease of 71.86%. The largest institutional shareholder is The Vanguard, holding a total of 623.05K shares, representing 2.03% of shares outstanding, with 148.31% increase in holdings.
Institutional Shareholding
No Data
Shareholder Activity
Highlander Partners, L.P.
Stifel, Nicolaus & Company, Incorporated
Rathbones Investment Management Limited
University of Texas Investment Management Company
Bridgeway Capital Management, LLC
UBS Financial Services, Inc.
Geode Capital Management, L.L.C.
Risk Assessment
Currency: USD Updated: 2025-11-05The company’s current risk assessment score is 2.53, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.91. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
0.91
240-Day Maximum Drawdown
+62.95%
240-Day Volatility
+119.67%
Volatility
Downside Risk-Adjusted Return
Maximum Daily Upside Volatility
Maximum Daily Downside Volatility
Healthcare Equipment & Supplies
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
CSTL
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
